Patent details

EP3117837 Title: ANTIBODY FORMULATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3117837
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16180643.5
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
28/08/2013
Grant date:
22/05/2019
EP Publication Date:
18/01/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
14/08/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/09/2020
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/05/2019
EP B1 Publication Date:
22/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/08/2033
Lapsed By Expiration Date:
Patent Validated Date:
22/08/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/05/2019
 
 

 

Name:
Bayer HealthCare LLC
Address:
100 Bayer Boulevard, WHIPPANY, NJ 07981-0915, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
21/08/2019
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
MA, Xinghang
Address:
Dublin, CA 94568, United States of America (US)

2

Name:
XIANG, Jun
Address:
San Ramon, CA 94583, United States of America (US)

Priority

1

Priority Patent Number:
201313843780
Priority Date:
15/03/2013
Priority Country:
United States of America (US)

2

Priority Patent Number:
201213601598
Priority Date:
31/08/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/395; C07K 16/38;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
14/21
Publication date:
07/04/2021
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
35/19
Publication date:
28/08/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
21/19
Publication date:
22/05/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201926
Publication date:
26/06/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201921
Publication date:
22/05/2019
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
14/08/2019
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
21/08/2019 Outgoing Correspondence Letter no formal defects 1 PDF /0/2/8/4/1/0800414820/docs/ep16180643.5_1_294752l271.pdf
14/08/2019 Claims First filed claims 2 PDF /0/2/8/4/1/0800414820/docs/ep16180643.5_0_claims20190814144545594.pdf